James Sapirstein has served over thirty five years in the pharmaceutical industry as well as thirty years in business management. He has been part of almost two dozen product launches and lead several large and small organizations with different levels of P&L responsibility. He started his career in sales and managed several sales and marketing organizations over his career. He has co-founded smaller companies and has been involved in several merger and acquisition deals over his career. He has held several CEO positions for publicly traded companies, most recently at AzurRx BioPharma. His skill sets include strategic planning, marketing and growing revenue streams.
Mr. Sapirstein received an MBA from Fairleigh Dickinson University in 1997, and a BS (Pharmacy) from Rutgers University in 1984. He was named as a Finalist for Ernst&Young Entrepreneur of the Year award in 2015 as well as in 2016.
Mr. Sapirstein holds board positions on Enochian Biosciences (ENOB), and Leading Biosciences. He was Chairman of the Board for BioNJ, an association of biopharma industries in New Jersey from Feb 2017-Feb 2019. In addition, he is a Board Director for BIO, the leading Biopharma Industries Organization promoting public policy and networking in the healthcare space, where he sits on both the Health Section and Emerging Companies Section Governing Boards.
Coaching differs greatly from therapy. That’s according to a Harvard Business Review survey which makes the distinction that coaching focuses on ...Read more
One of the most difficult things a leader will have to deal with in the workplace is the death of an employee. Whether the result of ongoing health ...Read more
In today's experience economy, businesses need to think of new ways to connect with customers and secure their loyalty. Customers expect not just ...Read more
The coronavirus epidemic has altered (perhaps permanently) many facets of life around the world. The business landscape, for one, is considerably ...Read more
It's hard to believe that 2020 is shortly coming to an end. For most of us, that may come as a relief, but the road to recovery is just beginning. ...Read more
What do you normally do when contemplating a major purchase? Like most people, you probably make an effort to see and hear what others have to say ...Read more
Working with a remote workforce requires different management and leadership. During the current Coronavirus pandemic, many members of your team will ...Read more
Getting to “Yes” is every salesperson’s ultimate goal. But so many variables are involved that the process can be cumbersome and aggravating—with no ...Read more
Whether your business has been positively or negatively affected by the impact of the pandemic, it has been impacted, and your business is not the ...Read more